SEC filing · 8-K

Altimmune, Inc.: Executive or director change

Altimmune appointed Richard Menziuso as Vice President, Global Controller and Principal Accounting Officer.

Filed September 29, 2026

Neutral news

What happened

On September 24, 2026, the Board appointed Richard Menziuso as Vice President, Global Controller and Principal Accounting Officer effective September 29, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Altimmune, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.